The Heart and Nutrition: Which Fatty Acids for Which Cardiac Function?;Cœur et Nutrition: Quels Acides Gras pour Quelle Fonction Cardiaque?

Archives des Maladies du Coeur et des Vaisseaux

Volumn 96, Issue SPEC. ISS. 6, 2003, Pages 7-12

  Grynberg, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; DOCOSAHEXAENOIC ACID; FATTY ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANTIARRHYTHMIC ACTIVITY; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CATABOLISM; DIET; FAT INTAKE; FATTY ACID OXIDATION; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART MITOCHONDRION; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE REPERFUSION; HEART VENTRICLE FUNCTION; HUMAN; MOLECULAR MECHANICS; MORBIDITY; MORTALITY; NUTRITION; OXYGEN CONSUMPTION; PROTEIN INTERACTION; REVIEW;

EID: 0242499190     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Pearson TA, Blair SN, Daniels SR et al. AHA Guidelines for primary prevention of cardiovascular disease and stroke: update 2002. Consensus Panel Guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 2002; 106: 388-91.
2. e ed., Paris: Tech. & Doc. Lavoisier; 2001.
3. Nordoy A. Dietary fatty acids and coronary heart disease. Lipids 1999; 34: S19-S22.
4. Abeywardena MY, McLennan PL, Charnock JS. Differences between in vivo and in vitro production of eicosanoids following long-term dietary fish oil supplementation in the rat. Prostaglandins Leukot Essent Fatty Acids 1991; 42: 159-65.
5. Hirai A, Terano T, Tamura Y, Yoshida S. Eicosapentaenoic acid and adult diseases in Japan: epidemiological and clinical aspects. J Intern Med (Suppl.) 1989; 225: 69-75.
6. Leaf A, Weber PC. Cardiovascular effects of n-3 fatty acids. N Eng J Med 1988; 318: 549-57.
7. Sellmayer A, Hrboticky N, Weber PC. Lipids in vascular function. Lipids 34 1999; S13-S18.
8. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr 1997; 66: 649-59.
9. GISSI group, Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-55.
10. Engler MM, Engler MB, Goodfriend TL et al. Docosahexaenoic acid is an antihypertensive nutrient that affects aldosterone production in SHR. Proc Soc Exp Biol Med 1999; 221: 32-8.
11. Rousseau D, Héliès C, Raederstorff D, Moreau D, Grynberg A. Dietary n-3 polyunsaturated fatty acids affect the development of reno-vascular hypertension in rats. Mol Cell Biochem 2001; 225: 109-19.
12. Rousseau D, Helies-Toussaint C, Moreau D, Raederstorff D, Grynberg A. Dietary n-3 PUFAs affect the blood pressure rise and carcliac function modulation in a hyperinsulinemia rat model in vivo. Am J Physiol 2003 (sous presse).
13. McLennan PL. Relative effects of dietary saturated, monounsaturated and polyunsaturated fatty acids on cardiac arrhythmias in the rat. Am J Clin Nutr 1992; 57: 207-12.
14. McLennan PL, Dallimore JA. Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats. J Nutr 1995; 125: 1003-9.
15. McLennan PL, Howe PR, Abeywardena MY et al. The cardiovascular protective role of docosahexaenoic acid. Eur J Pharmacol 1996; 300: 83-9.
16. McMurchie EJ, Burnard SL, Rinaldi JA, Patten GS, Neumann M, Gibson RA. Cardiac membrane lipid composition and adenylate cyclase activity following dietary eicosapentaenoic acid supplementation in the Marmoset monkey. J Nutr Biochem 1992; 3: 13-22.
17. Delerive P, Oudot F, Ponsard B et al. Hypoxia-reoxygenation and polyunsaturated fatty acids modulate adrenergic functions in cultured cardiomyocytes. J Mol Cell Cardiol 1999; 31: 377-86.
18. Ponsard B, Durot I, Delerive P et al. Cross influence of membrane PUFA and hypoxia reoxygenation on alpha- and beta-adrenergic function of rat cardiomyocytes. Lipids 1999; 34: 457-66.
19. Rousseau D, Moreau D, Raederstorff D et al. Is a dietary n-3 fatty acid supplement able to influence the cardiac effect of the psychological stress. Mol Cell Biochem 1998; 178: 353-66.
20. Bexis S, Lungershausen YK, Mano MT et al. Dietary fish oil administration retards blood pressure development and influences vascular properties in the spontaneously hypertensive rat (SHR) but not in the stroke prone-spontaneously hypertensive rat (SHR-SP). Blood Press 1994; 3: 120-6.
21. Vaskonen T, Laakso J, Mervaala E, Sievi E, Karppanen H. Interrelationships between salt and fish oil in stroke-prone spontaneously hypertensive rat. Blood Press 1996; 5: 178-89.
22. Chen HW, Lii CK, Chen WT, Wang ML, Hsu CC. Blood pressure-lowering effect of fish oil is independent of thromboxane A2 level in spontaneously hypertensive rats. Prostaglandins Leukot Essent Fatty Acids 1996; 54: 147-54.
23. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993; 88: 523-33.
24. Grimsgaard S, Bonaa KH, Hansen JB, Myhre ES. 1998. Effects of higly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr 68: 52-9.
25. Skou HA, Toft E, Christensen JH, Hansen JB, Dyerberg J, Schmidt EB. N-3 fatty acids and cardiac function after myocardial infarction in Denmark. Int J Circumpolar Health 2001; 60: 360-65.
26. Grynberg A. Métabolisme lipidique du myocarde dans "Biologie et pathologie du cœur et des vaisseaux. Paris: Flammarion Science, 2002.
27. Demaison L, Bouveret P, Grynberg A. Polyunsaturated Fatty Acid Composition and Lipid Metabolism in Cultured Cardiomyocytes and Isolated Working Rat Heart. Nutr Res 1993; 13: 1003-15.
28. Demaison L, Grynberg A. Influence of dietary linseed oil and sunflower seed oil on some mechanical and metabolic parameters of isolated working rat hearts. Reprod Nutr Dev 1991; 31: 37-45.
29. Demaison L, Sergiel JP, Moreau D, Grynberg A. Influence of the phospholipid n-6/n-3 polyunsaturated fatty acid ratio on mitochondrial oxidative metabolism before and after myocardial ischemia. Biochim Biophys Acta 1994; 53-9.
30. Yang B, Saldeen TG, Nichols WW, Mehta JL. Dietary fish oil supplementation attenuates myocardial dysfunction and injury caused by global ischemia and reperfusion in isolated rat hearts. J Nutr 1993; 123: 2067-74.
31. Pepe S, McLennan PL. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 2002; 105: 2303-8.
32. Jacobsson A, Pihl-Lindgren E, Fridlund B. Malnutrition in patients suffering from chronic heart failure; the nurse's care. Eur J Heart Fail 2001; 3: 449-56.
33. Anker SD, Ponikowski P, Varney S et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349: 1050-3.
34. Davos CH, Doehner W, Rauchhaus M et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003; 9: 29-35.